James T. Borello’s Cogent Biosciences COGT Stock Holding History

James T. Borello’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$96	Buy	+3	New	+$111	﹤0.01%	1205

Other funds holding COGT

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

James T. Borello's COGT Position: Q3 2026 in Review

James T. Borello opened a new position in Cogent Biosciences (COGT) in Q3 2026: 3 shares worth $96. The stake represents ﹤0.01% of the portfolio and ranks #1205 among its holdings.

43 funds tracked by Wall St. Rank hold COGT as of Q3 2026.

James T. Borello held 3 shares of Cogent Biosciences worth $96 as of Q3 2026.
Cogent Biosciences was a new James T. Borello position in Q3 2026.
Cogent Biosciences made up ﹤0.01% of James T. Borello's portfolio in Q3 2026, its #1205 holding.
43 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2026.

Based on James T. Borello's 13F filing for Q3 2026, filed 16 Oct 2026.